{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:48:43Z","timestamp":1773020923914,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.parkreldis.2022.105253","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:15:54Z","timestamp":1671480954000},"page":"105253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Screening for the FMR1 premutation in Greek patients with late-onset movement disorders"],"prefix":"10.1016","volume":"107","author":[{"given":"Chrisoula","family":"Kartanou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Seferiadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Pomoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Potagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrystalena","family":"Sofocleous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-5628","authenticated-orcid":false,"given":"Joanne","family":"Traeger-Synodinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3569-8990","authenticated-orcid":false,"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Panas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-8377","authenticated-orcid":false,"given":"Georgios","family":"Koutsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-5717","authenticated-orcid":false,"given":"Georgia","family":"Karadima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2022.105253_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/9.6.901","article-title":"Understanding the molecular basis of fragile X syndrome","volume":"9","author":"Jin","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2022.105253_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome-features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/gepi.20329","article-title":"Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity","volume":"32","author":"Hunter","year":"2008","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0796-1","article-title":"Composition of the intranuclear inclusions of fragile X-associated tremor\/ataxia syndrome","volume":"7","author":"Ma","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.parkreldis.2022.105253_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124391","article-title":"Fragile X-associated tremor\/ataxia syndrome (FXTAS): pathophysiology and clinical implications","volume":"21","author":"Cabal-Herrera","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2022.105253_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-019-01237-w","article-title":"MRI findings in fragile X-associated tremor\/ataxia syndrome","volume":"120","author":"Claeys","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.parkreldis.2022.105253_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/1866-1955-6-31","article-title":"Emerging topics in FXTAS","volume":"6","author":"Hall","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib8","article-title":"Parkinsonism in fragile X-associated tremor\/ataxia syndrome (FXTAS): revisited, Park","volume":"20","author":"Niu","year":"2014","journal-title":"Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awh535","article-title":"The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group","volume":"128","author":"Kamm","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.105253_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.60.1.117","article-title":"The fragile X premutation presenting as essential tremor","volume":"60","author":"Leehey","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib11","series-title":"Handb. Cerebellum Cerebellar Disord","article-title":"Idiopathic late onset cerebellar Ataxia (iloca), and cerebellar plus syndrome","author":"Tsuji","year":"2013"},{"key":"10.1016\/j.parkreldis.2022.105253_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0818-z","article-title":"Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology","volume":"7","author":"Sacino","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.parkreldis.2022.105253_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2012.03.019","article-title":"Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia","volume":"318","author":"Koutsis","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.105253_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.05.022","article-title":"Screening for spinocerebellar ataxia type 36 (SCA36)in the Greek population","volume":"402","author":"Katsimpouris","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.105253_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/cge.13960","article-title":"Biallelic RFC1 pentanucleotide repeat expansions in Greek patients with late-onset ataxia","volume":"100","author":"Kontogeorgiou","year":"2021","journal-title":"Clin. Genet."},{"key":"10.1016\/j.parkreldis.2022.105253_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/GIM.0b013e31820a780f","article-title":"High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses","volume":"13","author":"Chen","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.parkreldis.2022.105253_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-004-0558-1","article-title":"FMR1 premutation as a rare cause of late onset ataxia: evidence for FXTAS in female carriers [8]","volume":"251","author":"Z\u00fchlke","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib18","doi-asserted-by":"crossref","DOI":"10.1017\/S0317167100004431","article-title":"Adult onset spinocerebellar ataxia in a Canadian movement disorders clinic","volume":"32","author":"Kraft","year":"2005","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.105253_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-007-0020-3","article-title":"FXTAS in Spanish patients with ataxia: support for female FMR1 premutation screening","volume":"35","author":"Rodriguez-Revenga","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib20","article-title":"FXTAS, SCA10, and SCA17 in American patients with movement disorders [1]","volume":"136 A","author":"Seixas","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.parkreldis.2022.105253_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s10048-004-0200-5","article-title":"Expanded FMR1 alleles are rare in idiopathic Parkinson's disease [3]","volume":"6","author":"Tan","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2022.105253_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-014-0292-z","article-title":"Repeat-associated non-AUG translation and its impact in neurodegenerative disease","author":"Kearse","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2022.105253_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/mds.20297","article-title":"Parkinsonism, FXTAS, and FMR1 premutations","volume":"20","author":"Toft","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.64.7.1002","article-title":"Screen for excess FMR1 premutation alleles among males with Parkinsonism","volume":"64","author":"Kraff","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2008.548","article-title":"Screening for the presence of FMR1 premutation alleles in women with parkinsonism","volume":"66","author":"Cilia","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2022.105253_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines","volume":"22","author":"Berry-Kravis","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2013.10.012","article-title":"Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective","volume":"336","author":"Koutsis","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.105253_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2017.12.015","article-title":"The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and\/or dementia","author":"Breza","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2022.105253_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2008.04.037","article-title":"Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease","volume":"15","author":"Hall","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28086","article-title":"Fragile X gray zone alleles are associated with signs of parkinsonism and earlier death","volume":"35","author":"Hall","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27420","article-title":"Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females","volume":"33","author":"Loesch","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.105253_bib32","first-page":"22","article-title":"10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach","author":"Sofocleous","year":"2008","journal-title":"In Vivo (Brooklyn)"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022004229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022004229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:26:01Z","timestamp":1761179161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022004229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"alternative-id":["S1353802022004229"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.105253","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for the FMR1 premutation in Greek patients with late-onset movement disorders","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.105253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105253"}}